Here are three things to know:
1. Vivex Biomedical is a processor of human tissue, synthetics, mimetic patterning technology and biocellular products.
2. Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets.
3. As per the agreement, Xtant Medical will be entering the cellular bone graft market with a viable cell allograft, OsteoVive. Vivex will process the allograft for Xtant Medical and Xtant Medical will provide national distribution through its sales channels and national contract networks.
More articles on devices:
SpineGuard announces full-year 2015 financial results: 9 facts
Amedica successfully uses 3D printing to create silicon nitride devices: 4 things to know
5 points on the growing small bone & joint orthopedic devices market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
